34242 Federal Register / Vol. 86, No. 122 / Tuesday, June 29, 2021 / Notices 

in determining the scope and content of 

the environmental analysis. 

Russell Larson, 

Director, Portfolio Management Division, 

Pacific Rim Region, Public Buildings Service. 

[FR Doc. 2021–13828 Filed 6–28–21; 8:45 am] 

BILLING CODE 6820–YF–P 

GENERAL SERVICES 

ADMINISTRATION 

[OMB Control No. 3090–0080; Docket No. 

2021–0001; Sequence No. 3] 

Submission for OMB Review; General 

Services Administration Acquisition 

Regulation; Contract Financing Final 

Payment, GSA Form 1142, Release of 

Claims 

AGENCY: Office of Acquisition Policy, 

General Services Administration (GSA). 

ACTION: Notice of request for public 

comments regarding an extension to an 

existing OMB clearance. 

SUMMARY: Under the provisions of the 

Paperwork Reduction Act, the 

Regulatory Secretariat Division will be 

submitting to the Office of Management 

and Budget (OMB) a request to review 

and approve an extension of a 

previously approved information 

collection requirement of GSA Form 

1142, Release of Claims, regarding final 

payment under construction and 

building services contract. 

DATES: Submit comments on or before: 

July 29, 2021. 

ADDRESSES: Written comments and 

recommendations for this information 

collection should be sent within 30 days 

of publication of this notice to 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

Review—Open for Public Comments’’ or 

by using the search function. 

FOR FURTHER INFORMATION CONTACT: 

Bryon Boyer, Procurement Analyst, 

Office of Governmentwide Policy, by 

phone at 817–850–5580 or by email at 

gsarpolicy@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

The General Services Administration 

Acquisition Regulation (GSAR) clause 

552.232–72 requires construction and 

building services contractors to submit 

a release of claims before final payment 

is made to ensure contractors are paid 

in accordance with their contract 

requirements and for work performed. 

GSA Form 1142, Release of Claims is 

used to achieve uniformity and 

consistency in the release of claims 

process. 

B. Annual Reporting Burden 

Respondents: 1,330. 

Responses per Respondent: 1. 

Annual Responses: 1,330. 

Hours per Response: 0.10. 

Total Burden Hours: 133. 

C. Public Comments 

A notice published in the Federal 

Register at 86 FR 20159 on April 16, 

2021. No comments were received. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the Regulatory Secretariat Division by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 3090–0080; Contract 

Financing Final Payment, GSA Form 

1142, Release of Claims, in all 

correspondence. 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2021–13808 Filed 6–28–21; 8:45 am] 

BILLING CODE 6820–61–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Advisory Council on Alzheimer’s 

Research, Care, and Services; Meeting 

AGENCY: Assistant Secretary for 

Planning and Evaluation, HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces the 

public meeting of the Advisory Council 

on Alzheimer’s Research, Care, and 

Services (Advisory Council). The 

Advisory Council provides advice on 

how to prevent or reduce the burden of 

Alzheimer’s disease and related 

dementias on people with the disease 

and their caregivers. During the July 19, 

2021 meeting the Advisory Council will 

discuss the implications of and 

opportunities presented by the approval 

of aducanumab. The Council will also 

hear updates from federal workgroups 

on efforts undertaken in the last quarter. 

The risk reduction subcommittee will 

present a summary of their work and 

recommendations. The research, clinical 

care, and long-term services and 

supports subcommittees will present 

recommendations and the Council will 

vote on adopting them. 

DATES: The meeting will be held on July 

19, 2021 from 12:30 p.m. to 4:30 p.m. 

EST. 

ADDRESSES: The meeting will be virtual, 

streaming live at www.hhs.gov/live. 

Comments: Time is allocated on the 

agenda to hear public comments from 

4:00 p.m. to 4:30 p.m. The time for oral 

comments will be limited to two (2) 

minutes per individual. In order to 

provide a public comment, please 

register by emailing your name to 

napa@hhs.gov by Thursday, July 15. On 

Friday, July 16, registered commenters 

will receive both a dial-in number and 

a link to join the meeting virtually; 

individuals will have the choice to 

either join virtually via the link, or to 

call in only by using the dial-in number. 

Note: There may be a 30–45 second 

delay in the livestream video 

presentation of the conference. For this 

reason, if you have pre-registered to 

submit a public comment, it is 

important to connect to the meeting by 

3:45 p.m. to ensure that you do not miss 

your name and allotted time when 

called. If you miss your name and 

allotted time to speak, you may not be 

able to make your public comment. All 

participant audio lines will be muted for 

the duration of the meeting and only 

unmuted by the Host at the time of the 

participant’s public comment. Should 

you have questions during the session 

email napa@hhs.gov and someone will 

respond to your message as quickly as 

possible. 

In order to ensure accuracy, please 

submit a written copy of oral comments 

for the record by emailing napa@

hhs.gov by Tuesday, July 20. These 

comments will be shared on the website 

and reflected in the meeting minutes. 

In lieu of oral comments, formal 

written comments may be submitted for 

the record by Tuesday, July 20 to Helen 

Lamont, Ph.D., OASPE, 200 

Independence Avenue SW, Room 424E, 

Washington, DC 20201. Comments may 

also be sent to napa@hhs.gov. Those 

submitting written comments should 

identify themselves and any relevant 

organizational affiliations. 

FOR FURTHER INFORMATION CONTACT: 

Helen Lamont, 202–260–6075, 

helen.lamont@hhs.gov. Note: The 

meeting will be available to the public 

live at www.hhs.gov/live. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is given under the 

Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)(1) and 

(a)(2)). Topics of the Meeting: 

Aducanumab, dementia risk reduction, 

recommendations. 

Procedure and Agenda: The meeting 

will be webcast at www.hhs.gov/live and 

video recordings will be added to the 

National Alzheimer’s Project Act 

website when available, after the 

meeting. 

Authority: 42 U.S.C. 11225; Section 2(e)(3) 

of the National Alzheimer’s Project Act. The 

panel is governed by provisions of Public 


lotter on DSK11XQN23PROD with NOTICES1